Novo Nordisk market cap surpasses Tesla on new obesity pill trial data
March 08, 2024 at 04:53 AM EST
Wegovy obesity drug maker Novo Nordisk surpassed Tesla in market value Thursday after fresh early trial data showed positive results for its new experimental weight loss pill.
